MicroRNAs as potential biomarkers for the diagnosis of inflammatory bowel disease: a systematic review and meta-analysis
Open Access
- 20 April 2022
- journal article
- review article
- Published by SAGE Publications in Journal of International Medical Research
- Vol. 50 (4)
Abstract
Objective: The clinical importance of aberrantly expressed microRNAs (miRNAs) in diagnosing inflammatory bowel disease (IBD) has not been well established, so was investigated in this systematic review and meta-analysis. Methods: Articles in online databases from inception to March 17, 2021 were retrieved. Random effects meta-analysis was used to obtain sensitivity, specificity, positive (PLRs) and negative likelihood ratios (NLRs), diagnostic odds ratios (DORs), and areas under the curve (AUC) with 95% confidence intervals (CI) for IBD diagnosis. Results: Of 117 studies reporting altered miRNA expression in IBD included in the systematic review, 15 involving 937 patients with IBD and 707 controls, 22 miRNAs, and two miRNA panels were eligible for meta-analysis. Pooled analyses showed a moderate diagnostic accuracy for miRNAs in the IBD diagnosis, with a sensitivity of 0.80 (95% CI: 0.79–0.82), specificity of 0.84 (95% CI: 0.82–0.86), DOR of 21.19 (95% CI: 13.90–32.31), and AUC of 0.89. Subgroup analyses revealed a better performance in patients with ulcerative colitis (AUC, 0.93) than Crohn’s disease (AUC, 0.84). Consistent upregulation of miR-21, miR-16, and miR-192 in blood with a high-moderate diagnostic accuracy was found in at least two studies. Conclusions: These findings suggest miRNAs are credible diagnostic biomarkers in IBD.Keywords
Funding Information
- the research grant from Xi’an Children’s Hospital Program (2019D06, 2020A08)
- Youth Development Funds by Xi’an Municipal Health Commission (2020qn14)
- The Basic Research Program of Shaanxi Natural Science Foundation (2020JQ-928)
This publication has 34 references indexed in Scilit:
- Assessment of Circulating MicroRNAs for the Diagnosis and Disease Activity Evaluation in Patients with Ulcerative Colitis by Using the Nanostring TechnologyInflammatory Bowel Diseases, 2015
- miR-301a promotes intestinal mucosal inflammation through induction of IL-17A and TNF-α in IBDGut, 2015
- Circulating microRNAs as biomarkers of adult Crohn’s diseaseEuropean Journal of Gastroenterology & Hepatology, 2015
- Genome-Wide Maps of Circulating miRNA Biomarkers for Ulcerative ColitisPLOS ONE, 2012
- QUADAS-2: A Revised Tool for the Quality Assessment of Diagnostic Accuracy StudiesAnnals of Internal Medicine, 2011
- MicroRNAs in Development and DiseasePhysiological Reviews, 2011
- Circulating MicroRNA Is a Biomarker of Pediatric Crohn DiseaseJournal of Pediatric Gastroenterology and Nutrition, 2011
- The performance of tests of publication bias and other sample size effects in systematic reviews of diagnostic test accuracy was assessedJournal of Clinical Epidemiology, 2005
- Measuring inconsistency in meta-analysesBMJ, 2003
- Inflammatory Bowel DiseaseNew England Journal of Medicine, 2002